IGC AMEX
IGC Pharma, Inc.
1W: -2.7%
1M: -7.1%
3M: -2.2%
YTD: -5.5%
1Y: -33.2%
3Y: -23.1%
5Y: -82.0%
$0.27
+0.00 (+1.81%)
Weekly Expected Move ±5.9%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
9 relationships9
As Filer
counterparties named
0
As Counterparty
mentioned by others
6
Rel. Types
2022-05-12
Earliest Filing
2025-11-14
Latest Filing
customer: 3
licensee: 2
supplier: 1
acquirer: 1
investor: 1
partner: 1
Counterparties (Filed by IGC)
9 relationshipsCompanies named in IGC's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Wellness Essentials Northwest LLC | — | customer | Purchased equipment, inventory, and operating assets from Holi Hemp LLC for approximately $2.7 million. | 2025-11-14 | View |
| Holi Hemp LLC | — | supplier | Seller of equipment, inventory, and facility in a $2.7 million asset sale | 2025-10-01 | View |
| Wellness Essentials Northwest Inc. | — | customer | Buyer of equipment, inventory, and facility in a $2.7 million asset sale | 2025-10-01 | View |
| Wellness Northwest Inc. | — | customer | Buyer of equipment, inventory, and facility in a $2.7 million asset sale (listed in Exhibit 10.1) | 2025-10-01 | View |
| IGC Pharma, Inc. | IGC | acquirer | Company issuing shares to Investor in a stock purchase agreement. | 2024-03-28 | View |
| Bradbury Strategic Investment Fund A | — | investor | Investor purchasing shares from IGC Pharma, Inc. | 2024-03-28 | View |
| A.G.P./Alliance Global Partners | — | partner | Sales Agent for the issuance and sale of the Company's common stock. | 2023-10-27 | View |
| Jawaharlal Nehru Centre for Advanced Scientific Research | — | licensee | Licensor of patent rights for NMI Compounds | 2022-05-12 | View |
| Hamsa Biopharma India Private Limited | — | licensee | Licensee granted rights to manufacture and sell NMI Compounds | 2022-05-12 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-07-14 | Regulation FD; Exhibits | View | |
| 2026-07-06 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-06-08 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-04-20 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-03-30 | Other Events; Exhibits | View | |
| 2026-03-12 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2026-01-06 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2026-01-02 | Amendments to Articles of Incorporation or Bylaws | View | |
| 2025-12-15 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-11-14 | Completion of Acquisition or Disposition of Assets; Financial Statements and Exhibits | Acquisition | View |
| 2025-10-14 | Submission of Matters to a Vote of Security Holders; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-01 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-06-17 | Other Events; Financial Statements and Exhibits | View | |
| 2024-08-02 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2024-04-05 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-03-28 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2023-10-27 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2023-08-21 | Submission of Matters to a Vote of Security Holders; Other Events; Financial Statements and Exhibits | View | |
| 2023-03-21 | Amendments to Articles of Incorporation or Bylaws; Regulation FD Disclosure; Financial Statements an | View | |
| 2022-12-29 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR